Research workbench
Crystal structure of SARS coronavirus main proteinase (3CLPRO)
Analyse Crystal structure of SARS coronavirus main proteinase (3CLPRO) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 1UJ1
- Type
- protein
- Length
- 603 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- 3C-like proteinase
- EC
- 3.4.24.-
- UniProt
- P59641
- Pockets
- 6 · best druggability 0.74
Structure
x-ray diffraction · 2 distinct chains · 27% helix, 30% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | 3C-like proteinase (EC 3.4.24.-) | protein | 301 | 27% helix, 30% strand | P59641 |
| B | 3C-like proteinase (EC 3.4.24.-) | protein | 302 | 26% helix, 29% strand | P59641 |
Pockets
6 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 912 | 0.74 | 0.78 | 64 | empty |
| 2 | 525 | 0.64 | 0.76 | 81 | empty |
| 3 | 269 | 0.59 | 0.79 | 36 | empty |
| 4 | 120 | 0.44 | 0.77 | 26 | empty |
| 5 | 137 | 0.39 | 0.74 | 22 | empty |
Interfaces
1 interface between chains.
- A–B · 1171 Ų buried · 27 hydrogen bonds · protein-protein
Compared structures
- 1UJ1 · Crystal structure of SARS Coronavirus Main Proteinase (3CLpro) · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P59641
- Elsewhere: RCSB PDB 1UJ1 · PDBe 1UJ1 · UniProt P59641
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.